27 AprLeading researcher says Dr.

Leading researcher says Dr. Darren Treanor of the University of Leeds and Leeds Teaching Hospitals NHS Trust in the UK:’The use of 3D imaging technology, structure, function and disease manifestations study was limited because of the low resolution, and the time and effort associated with the acquisition of of a large number of images with a microscope. Our system tissue can integrate micro-architecture and cellular morphology on large tissue samples.

‘courtesy of you, the entire Kaiser Daily Health Policy Report display, search the archives, or sign up for e-mail delivery on Kaiser Daily Health Policy Report published emphasis of imperial network. A free service of The Henry J. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.The researchers were capable of replicating the connection between one of the markers of previous studies, and is an increased risk detected. More importantly they found an the new genetic marker, announced as rs7008482 which was associated even more having prostate cancer in African Americans. This mark has within a gene DNA replication involved in DNA replication, recombination of and repair.

Change this gene could lead to confer an hereditary predisposition to genetic instability, Kittles said. This may By studying risk of cancer. By studying this region, we are can may be will be able to develop of molecular targets to improve screening, early diagnosis and possibly treat. .